89 related articles for article (PubMed ID: 8553857)
1. Pathways of aggrecan processing in joint tissues. Implications for disease mechanism and monitoring.
Sandy JD; Plaas AH; Koob TJ
Acta Orthop Scand Suppl; 1995 Oct; 266():26-32. PubMed ID: 8553857
[No Abstract] [Full Text] [Related]
2. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
Lohmander LS
J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
[TBL] [Abstract][Full Text] [Related]
3. Topographic variation in biglycan and decorin synthesis by articular cartilage in the early stages of osteoarthritis: an experimental study in sheep.
Little CB; Ghosh P; Bellenger CR
J Orthop Res; 1996 May; 14(3):433-44. PubMed ID: 8676257
[TBL] [Abstract][Full Text] [Related]
4. The structure of aggrecan and its turnover in cartilage.
Hardingham TE; Fosang AJ
J Rheumatol Suppl; 1995 Feb; 43():86-90. PubMed ID: 7752148
[TBL] [Abstract][Full Text] [Related]
5. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
[TBL] [Abstract][Full Text] [Related]
6. High levels of aggrecan aggregate components are present in synovial fluids from human knee joints with chronic injury or osteoarthrosis.
Ratcliffe A; Grelsamer RP; Kiernan H; Saed-Nejad F; Visco D
Acta Orthop Scand Suppl; 1995 Oct; 266():111-5. PubMed ID: 8553838
[No Abstract] [Full Text] [Related]
7. Aggrecan degradation in osteoarthritis and rheumatoid arthritis.
Lark MW; Bayne EK; Lohmander LS
Acta Orthop Scand Suppl; 1995 Oct; 266():92-7. PubMed ID: 8553869
[No Abstract] [Full Text] [Related]
8. Kinetics of release of aggrecan from explant cultures of bovine cartilage from different sources and from animals of different ages.
Ilic MZ; Haynes SR; Winter GM; Handley CJ
Acta Orthop Scand Suppl; 1995 Oct; 266():33-7. PubMed ID: 8553858
[No Abstract] [Full Text] [Related]
9. Keratan sulfate in body fluids in joint disease.
Thonar EJ; Masuda K; Häuselmann HJ; Uebelhart D; Lenz ME; Manicourt DH
Acta Orthop Scand Suppl; 1995 Oct; 266():103-6. PubMed ID: 8553836
[No Abstract] [Full Text] [Related]
10. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
Lohmander LS; Ionescu M; Jugessur H; Poole AR
Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
[TBL] [Abstract][Full Text] [Related]
11. Alterations in cartilage type-II procollagen and aggrecan contents in synovial fluid in equine osteochondrosis.
Laverty S; Ionescu M; Marcoux M; Bouré L; Doizé B; Poole AR
J Orthop Res; 2000 May; 18(3):399-405. PubMed ID: 10937626
[TBL] [Abstract][Full Text] [Related]
12. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
13. Matrix protein mRNA levels in canine meniscus cells in vitro.
Wildey GM; McDevitt CA
Arch Biochem Biophys; 1998 May; 353(1):10-5. PubMed ID: 9578595
[TBL] [Abstract][Full Text] [Related]
14. Sulphation heterogeneity in the trisaccharide (GalNAcSbeta1, 4GlcAbeta1,3GalNAcS) isolated from the non-reducing terminal of human aggrecan chondroitin sulphate.
West LA; Roughley P; Nelson FR; Plaas AH
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):223-9. PubMed ID: 10432320
[TBL] [Abstract][Full Text] [Related]
15. Use of synovial fluid markers of cartilage synthesis and turnover to study effects of repeated intra-articular administration of methylprednisolone acetate on articular cartilage in vivo.
Robion FC; Doizé B; Bouré L; Marcoux M; Ionescu M; Reiner A; Poole AR; Laverty S
J Orthop Res; 2001 Mar; 19(2):250-8. PubMed ID: 11347698
[TBL] [Abstract][Full Text] [Related]
16. Enhanced concentration of COMP (cartilage oligomeric matrix protein) in osteochondral fractures from racing Thoroughbreds.
Skiöldebrand E; Heinegård D; Eloranta ML; Nilsson G; Dudhia J; Sandgren B; Ekman S
J Orthop Res; 2005 Jan; 23(1):156-63. PubMed ID: 15607888
[TBL] [Abstract][Full Text] [Related]
17. Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage.
Poole AR; Rosenberg LC; Reiner A; Ionescu M; Bogoch E; Roughley PJ
J Orthop Res; 1996 Sep; 14(5):681-9. PubMed ID: 8893759
[TBL] [Abstract][Full Text] [Related]
18. Identification of the motifs and amino acids in aggrecan G1 and G2 domains involved in product secretion.
Kiani C; Chen L; Lee V; Zheng PS; Wu Y; Wen J; Cao L; Adams ME; Sheng W; Yang BB
Biochemistry; 2003 Jun; 42(23):7226-37. PubMed ID: 12795619
[TBL] [Abstract][Full Text] [Related]
19. Effect of link protein concentration on articular cartilage proteoglycan aggregation.
Tang LH; Buckwalter JA; Rosenberg LC
J Orthop Res; 1996 Mar; 14(2):334-9. PubMed ID: 8648515
[TBL] [Abstract][Full Text] [Related]
20. The concentration, gene expression, and spatial distribution of aggrecan in canine articular cartilage, meniscus, and anterior and posterior cruciate ligaments: a new molecular distinction between hyaline cartilage and fibrocartilage in the knee joint.
Valiyaveettil M; Mort JS; McDevitt CA
Connect Tissue Res; 2005; 46(2):83-91. PubMed ID: 16019418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
